Vita Life Sciences Limited · ASX:VLS

Vita Life Sciences — H1 2012 Earnings Presentation

8 slides from Vita Life Sciences's earnings presentation, Aug 28, 2012

  1. Slide 1: Half Yearly Results Presentation

    Vita Life Science 30 June 2 Half Yearly Results Presentation 28 August 2012 ASX Code: VSC

  2. Slide 2: Excellent sales growth of 27.2%

     Excellent sales growth of 27.2%  Record PBT of $1.10 million  Interim Dividend of 0 0.5 5 cents per share fully franked to be paid in October 2012  New N b business i units it starting t ti tto contribute t ib t meaningful i f l revenue stream 1

  3. Slide 3: Half year ended 30 June 2012

    Half year ended 30 June 2012 2011 % Change A $'m A $'m Revenue 14.41 11.33 27.2% EBITDA 1.22 0.57 114.3% Profit Before Tax 1.10 0.45 144.2% Profit After Tax 0 99 0.99 0 37 0.37 167 4% 167.4% EPS (Diluted - cents/share) 1.72 0.64 168.8% Dividend (cents/share) 0.50 0.00 100% Cash Conversion # 117.6% N

  4. Slide 4: Strong balance sheet with no debt

    Balance Sheet ($'m) 30 June 31 December 2012 2011 Current assets 13.77 10.93  Strong balance sheet with no debt Non-current assets 1.71 2.42 Total assets 15.48 13.35  Cash and cash equivalents make up 48% of net assets Current liabilities 5.38 4.37  Net tangible assets are Non-current liabilities

  5. Slide 5: Sales growth (in local currency)

    Revenue ‐ $'m $' 6 months to 30 June 16 14 Other  2012 Sales grew by 27% (23% excluding the change in accou accounting t g for o tthe e Thai a 12 Singapore 10 Group) Malaysia Sales growth (in local 8  6 currency)  Australia – 30% 4  Malaysia - 23% Australia  Singapore – 9% 2 0  New Business un

  6. Slide 6: Thailand, Malaysia MLM, China, Vietnam and Indonesia

    Thailand  51% sales growth (in local currency) and profitable  Now a subsidiary of the Group Multi-Level Marketing in Malaysia  Sales decreased by 6% (in local currency) due to transition to a new marketing strategy in July 2012 China  Sales grew by 52% (in local currency) with a small loss Viet

  7. Slide 7: Underlying profits are growing strongly

    Profit Before Tax ($'m) 6 months to 30 June 1.2 1 Underlying profits are 0.8  0.6 growing strongly with a Compound Annual Growth 0.4 Rate of 48% 02 0.2 0 2009 2010 2011 2012 Underlying Profit 6

  8. Slide 8: Outlook for the second half

     Established Business Units expected to perform in line with current growth rates for the second half of the yyear. g  Barring unforeseen circumstances NPAT for the second half of the year expected to be similar to the first half.  Focus on expansion strategy in China, Indonesia, Malaysia, Thaila

Vita Life Sciences — H1 2012 Earnings Presentation on 6ix